PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
PASSCODE(胰腺腺癌基质重编程联盟协调、数据管理和教育)
基本信息
- 批准号:10517527
- 负责人:
- 金额:$ 97.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AmericanAmerican Cancer SocietyAreaBasic ScienceBioinformaticsBiological AssayBiometryCancer BiologyCancer EtiologyCatalogingCellsCharacteristicsClinicalClinical Trials DesignCollaborationsCommunicationCommunitiesComputational BiologyCuesDataData CollectionData ScienceData Storage and RetrievalDesmoplasticDiagnosisDiseaseDisease OutcomeEcosystemEducationEducational ActivitiesEducational workshopElementsEnsureExtracellular MatrixFacility AccessesFibroblastsFundingGeneticGoalsGroup MeetingsGrowthHeterogeneityImmuneInfrastructureIntranetLogisticsLymphovascularMalignant NeoplasmsMalignant neoplasm of pancreasMentorshipMissionMolecularOutcomePancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPathogenesisPathologyPatientsPersonsPlayPoliciesProceduresReagentRegistriesRegulationResearchResearch ActivityResearch PersonnelRoleSecureShort Interspersed Nucleotide ElementsSiteSite VisitSolidSpecificityStromal NeoplasmSystemTherapeuticTimeTissuesTransfer AgreementTranslational ResearchTwitterUnderrepresented MinorityUnited StatesUnited States National Institutes of Healthanalytical toolbasebiobankcancer geneticscloud basedcomputing resourcesdata disseminationdata exchangedata harmonizationdata managementimprovedinnovationmaterial transfer agreementmeetingsmemberminority traineemolecular pathologymortalitymultidisciplinarymultimodal dataneoplastic celloutreachpancreas visualizationpancreatic tumorigenesisprogramsresearch studyresponseshared databasesocial mediasuccesssurvival outcomesymposiumtumortumor immunologytumor microbiometumor microenvironmentvirtualweb siteworking group
项目摘要
ABSTRACT
A defining feature of Pancreatic ductal adenocarcinoma (PDAC) is the presence of a host stromal response,
which is characteristically more robust (“desmoplastic”) than many solid cancers. Stromal elements, including
cancer-associated fibroblasts (CAFs) and the extracellular matrix, are pivotal components of the tumor
microenvironment (TME) ecosystem in PDAC, which also includes immune cells, the lymphovascular system,
and the intra-tumoral microbiome. In recent years the role of the PDAC stroma (and CAFs, in particular) has
morphed to one characterized by profound heterogeneity, plasticity, and context-specificity. The newly created
Pancreatic Cancer Stromal Reprogramming Consortium (PSRC) will fund a team of six U01 sites to conduct
basic and translational research studies on the role of the stroma and other TME constituents in PDAC
pathogenesis and outcomes. We have collated a multidisciplinary team of investigators at UT MD Anderson with
the goal of creating PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium
COordination, Data Management and Education Center), that will serve as an organizing “hub” for coordination,
communication and collaboration within the PSRC, and support the newly funded U01 sites. PASSCODE will be
co-led by Dr. Anirban Maitra, an expert in PDAC pathology, genetics, and cancer biology, and Dr. J. Jack Lee,
an expert in biostatistics, clinical trial design and data science. PASSCODE proposes four aims: First, we will
support the administrative infrastructure of the PSRC, and ensure effective communication and collaboration
between consortium investigators, the NCI program office and other trans-NCI networks, including facilitating all
of the PSRC-approved in-person and virtual meetings. We will also provide operational support for material and
data transfer agreements that are germane to the collaborative studies within the PSRC. Second, we will develop
a framework for a PSRC “virtual biorepository” as a registry database for shared biospecimen access across the
consortium, and develop SOPs for processing, storage, cataloging, and distribution of annotated biospecimens
and de-identified clinical, demographic, and molecular information. Third, we will provide centralized data
management and data storage capabilities for the PSRC, with the overarching goal of data harmonization and
dissemination, within and beyond the consortium. As part of this aim, PASSCODE will provide dedicated
biostatistical and bioinformatics analytical tools, and multimodal data visualization for PSRC investigators,
including for approved collaborative projects. Fourth, PASSCODE will be responsible for developing and
maintaining both a “public facing” PSRC website and other social media outlets, as well as a secure intranet site.
We will organize seminars and workshops that highlight progress within the PSRC, and provide a platform for
educational/mentorship opportunities, especially with regards to enhancing the participation of underrepresented
minority trainees. Cumulatively, PASSCODE’s activities will be geared towards ensuring the success of the
consortium’s mission of improving PDAC survival through innovative and collaborative research endeavors.
摘要
胰腺导管腺癌(PDAC)的一个定义特征是存在宿主间质反应,
其特征性地比许多实体癌更强健(“促结缔组织增生”)。基质成分,包括
癌相关成纤维细胞(CAF)和细胞外基质是肿瘤的关键成分
PDAC中的微环境(TME)生态系统,其中还包括免疫细胞,淋巴血管系统,
和肿瘤内的微生物组。近年来,PDAC基质(特别是CAF)的作用已被证实。
演变为一个具有深刻的异质性,可塑性和上下文特异性的特点。新创建的
胰腺癌基质重编程联盟(PSRC)将资助一个由六个U 01研究中心组成的团队,
PDAC中基质和其他TME成分作用的基础和转化研究
发病机制和结果。我们整理了UT MD安德森的多学科研究团队,
创建PASSCODE(胰腺癌基质重编程联合体)的目的
协调、数据管理和教育中心),将作为协调的组织“中心”,
PSRC内部的沟通和协作,并支持新资助的U 01站点。PASSCODE将成为
由PDAC病理学、遗传学和癌症生物学专家Anirban Maitra博士和J. Jack Lee博士共同领导,
生物统计学、临床试验设计和数据科学专家。PASSCODE提出了四个目标:第一,我们将
支持PSRC的行政基础设施,并确保有效的沟通和协作
联盟调查人员、NCI项目办公室和其他跨NCI网络之间的联系,包括促进所有
PSRC批准的面对面和虚拟会议。我们还将提供物资和
与PSRC内的合作研究密切相关的数据传输协议。第二,我们将发展
一个PSRC“虚拟生物库”框架,作为跨区域共享生物标本访问的注册数据库。
联合体,并制定标准操作规程,用于处理、储存、编目和分发带注释的生物标本
以及去识别的临床、人口统计学和分子信息。第三,我们将提供集中的数据
PSRC的管理和数据存储能力,其总体目标是数据协调和
在联合体内外传播。作为这一目标的一部分,PASSCODE将提供专门的
生物统计和生物信息学分析工具,以及PSRC研究人员的多模式数据可视化,
包括已批准的合作项目。第四,PASSCODE将负责开发和
维持一个“面向公众”的PSRC网站和其他社交媒体渠道,以及一个安全的内联网网站。
我们将举办研讨会和讲习班,重点介绍私营部门改革委员会的进展,并提供一个平台,
教育/指导机会,特别是在加强任职人数不足的人的参与方面
少数民族学员。PASSCODE的活动将逐步面向确保
联盟的使命,提高PDAC生存通过创新和合作研究的努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J. Jack LEE其他文献
J. Jack LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J. Jack LEE', 18)}}的其他基金
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
PASSCODE(胰腺腺癌基质重编程联盟协调、数据管理和教育)
- 批准号:
10705730 - 财政年份:2022
- 资助金额:
$ 97.2万 - 项目类别:
相似海外基金
Improving Vaccination Rates Nationwide through Partnerships between the American Cancer Society
通过美国癌症协会之间的合作提高全国范围内的疫苗接种率
- 批准号:
8916862 - 财政年份:2014
- 资助金额:
$ 97.2万 - 项目类别:














{{item.name}}会员




